Meeder Asset Management Inc Heron Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$10.89 - $21.47 $1,197 - $2,361	-110 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $3,201 - $7,687	-313 Reduced 74.0%	110 $1,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $7,246 - $11,069	416 Added 5942.86%	423 $10,000
Q2 2019 Aug 05, 2019	BUY	$16.93 - $26.22 $118 - $183	7 New	7 $0
Q3 2018 Nov 02, 2018	SELL	$30.0 - $40.85 $4,230 - $5,759	-141 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$26.4 - $42.0 $3,722 - $5,922	141 New	141 $0

174

114M

1.99M

65.8K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $211M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.